Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clever Leaves Holdings Inc. - Warrant (NQ: CLVRW )

N/A UNCHANGED
Last Price Updated: 3:56 PM EDT, May 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.0101 (99)
Ask (Size) 0.0220 (129)
Prev. Close 0.0164
Today's Range N/A - N/A
52wk Range 0.0010 - 0.0500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions
Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) reported its financial results late Monday for the fourth quarter and full year concluded on December 31, 2023.  
Via Benzinga
Topics Cannabis
Exposures Cannabis
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why
The European cannabis market is one of the most rapidly expanding markets globally.Prohibition Partners revealed in its latest report on cannabis in Europe that the combined market size of all CBD... 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

More News

Read More
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Via Benzinga
Topics Cannabis
Exposures Cannabis
Colombia's President Wants Weed Legalized Despite Senate Opposition: Prohibition Increases 'Profits Of Drug Trafficking, Violence'
Via Benzinga
Topics Cannabis
Exposures Cannabis
Clever Leaves Fights Back: Bold Moves Secure Its NASDAQ Position Amid Global Cannabis Market Uncertainties
Via Benzinga
Topics Cannabis
Exposures Cannabis
Clever Leaves Shares Trading Higher On Its Colombian Cannabis Launching In Australia
Via Benzinga
Clever Leaves Sells Cannabis Processing Facility In Portugal To Curaleaf's Subsidiary
Via Benzinga
Clever Leaves Teams Up With SOMAÍ Pharma., Completes First CBD Extract Shipments To Portugal
Via Benzinga
Clever Leaves' Q1 Net Loss Drops Significantly After Operating Expenses Slashed By 48%
Via Benzinga
Clever Leaves Teams Up With Hypera Pharma To Supply CBD-Dominant Oral Solutions For Brazilian Patients
Via Benzinga
Clever Leaves And Praetorian Team Up To Produce Cannabis Genetics In Colombia
Via Benzinga
Cannabis Operator Makes Extremely Difficult Decision To Lay Off 63 Employees For Expected Savings Of $7M
Via Benzinga
Clever Leaves Q3 Revenue Declines 18% YoY, Provides Outlook
Via Benzinga
Clever Leaves To Bring Its THC Dominant Oral Solution To Peru Via Partnership With Anden Naturals
Via Benzinga
Clever Leaves To Grow & Commercialize House Of Kush THC Flower For International Cannabis Markets
Via Benzinga
Cannabis Company Sannabis Partners With Occupational Health Services Provider In Colombia
Via Benzinga
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
Via Benzinga
Clever Leaves 2Q: Neutraceuticals Up, Preparing For Cannabis Flower Exports From Colombia
Via Benzinga
Improving Balance Sheet Is Paying Off For Clever Leaves, Q2 Revenue Grows 27% YoY
Via Benzinga
Clever Leaves To Ship First Export Of Cannabis To Israeli Partner InterCure
Via Benzinga
Cantourage And Clever Leaves Intensify Partnership For Distribution Of Medical Cannabis In Germany
Via Benzinga
Clever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2M
Via Benzinga
Clever Leaves Affiliate Now Fully Licensed To Distribute Medical Cannabis In Germany
Via Benzinga
Clever Leaves Partners With Biom Therapeutics As Supplier Of Pharmaceutical-Grade CBD Used In Clinical Trials
Via Benzinga
Why Is Clever Leaves Stock Surging 140%? Look To Washington DC Next Week For The Answer
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.